BeiGene
BGNE
#914
Rank
C$30.38 B
Marketcap
$269.81
Share price
-0.39%
Change (1 day)
4.64%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $562.13 CAD on 2021-09-17

Lowest end of day price: $33.44 CAD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.39-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.18-0.95%๐Ÿ‡บ๐Ÿ‡ธ USA